The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their crucial role in global healthcare. This move reinforces India’s position as a key provider of affordable generic medicines. Leaders highlight the strategic importance of the bilateral trade relationship, with the exemption offering India a chance to enhance its pharmaceutical sector.
Related Posts
26/11 Mumbai attack turning point between India-Pak ties: Jaishankar
S. Jaishankar criticized Pakistan’s role in promoting terrorism, highlighting their double-dealing in Afghanistan and persistent “bad habits.” He emphasized that the 2008 Mumbai attacks marked […]
Elon Musk to take on DeepSeek with GrokAI 3, AI chatbot he went ‘offline’ for
Elon Musk’s xAI is set to unveil Grok 3 on Monday, claimed as the smartest AI on Earth after outperforming other models in testing. Grok […]
Five simple ways Marco Rubio wants to improve US-India relations
Senator Marco Rubio’s United States-India Defense Cooperation Act of 2024 is designed to enhance the defense relationship between the US and India. By supporting India’s […]